RY is employed at Novartis Oncology, and owns Novartis stock.
Molecular diagnosis and targeted therapy of a pediatric chronic eosinophilic leukemia patient carrying TPM3-PDGFRB Fusion†
Article first published online: 11 NOV 2010
Copyright © 2010 Wiley-Liss, Inc.
Pediatric Blood & Cancer
Volume 56, Issue 3, pages 463–466, March 2011
How to Cite
Li, Z., Yang, R., Zhao, J., Yuan, R., Lu, Q., Li, Q. and Tse, W. (2011), Molecular diagnosis and targeted therapy of a pediatric chronic eosinophilic leukemia patient carrying TPM3-PDGFRB Fusion. Pediatr. Blood Cancer, 56: 463–466. doi: 10.1002/pbc.22800
Conflict of interest: Nothing to declare.
- Issue published online: 10 JAN 2011
- Article first published online: 11 NOV 2010
- Manuscript Accepted: 26 JUL 2010
- Manuscript Received: 21 APR 2010
- Medical College of Xiamen University (“985” Program)
Additional Supporting Information may be found in the online version of this article.
|PBC_22800_sm_SuppFig1.eps||587K||Supplemental Figure 1|
|PBC_22800_sm_SuppFig2.eps||1152K||Supplemental Figure 2|
|PBC_22800_sm_SuppFig3.eps||1124K||Supplemental Figure 3|
|PBC_22800_sm_SuppFigLegend.doc||34K||Supplementary Figure legend|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.